Q0175
Q0175 – Perphenazine, 4 mg, oral, fda approved prescription anti-emetic, for use · NDC Crosswalk & Billing Units
HCPCS Level II Q-code · Medicare Part B drug billing
Q-code
● 33 NDCs crosswalked
📋 Q0175 summary
Q0175 is a HCPCS Level II Q-code used to bill Perphenazine, 4 mg, oral, fda approved prescription anti-emetic, for use as a complete the.... The number of billing units to report depends on the dose administered and the NDC/package billed — use the calculator below.
⚠ An NDC↔HCPCS crosswalk and a published payment limit do not guarantee payer coverage or payment. Always verify the current payer policy and claim format before billing.
🗂️ Key billing facts
HCPCS codeQ0175
DescriptorPerphenazine, 4 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Billing unitNot available in current dataset
Payment limit / unit Not available in current dataset
Mapped NDCs33
Data periodNot available in current dataset
Last updatedSource date not available
💊 About Perphenazine DRUG GUIDE
Perphenazine tablets treat schizophrenia.
They also control severe nausea and vomiting in adults.Perphenazine has not been shown to work for behavior problems in people with intellectual disability.
It is not approved for dementia-related psychosis.
Clinical overview from our editorial drug guide for Perphenazine. For billing reference, see the sections above.
🧾 Billing & reimbursement HCPCS · CMS
Medicare payment limit / unit
—
Est. ASP / unit
—
Est. after 2% sequester
—
HCPCS dosage
—
The CMS payment limit is the Medicare Part B drug allowance (ASP + 6%, statutory). After the 2% federal sequester the effective payment is ≈ ASP + 4.3%; estimated ASP = payment limit ÷ 1.06. Source: CMS Medicare Part B Payment Limit File (quarterly).
Full HCPCS code details (official CMS record)
Long descriptionPerphenazine, 4 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
CoverageD — Special coverage instructions apply
Pricing indicator51 — Drug — priced under the ASP methodology
Type of service1 — Medical care
BETOS-2O1D
ASC payment group—
Action codeN — No maintenance this year
Effective date1998-04-01
Date added1998-04-01
Source: CMS HCPCS Level II code file (imported via admin).
🧮 Dosing & billing-units calculator HCPCS UNITS
One billing unit of Q0175 = 1 unit. Enter a regimen to convert dose → billing units and project a full course.
Billing units = dose ÷ HCPCS unit size. Most payers require whole units — round per the payer's policy. “Est. Medicare pay” uses the current payment limit. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (JZ when none is discarded) where allowed. Always verify payer-specific rounding before billing.
🔁 NDCs that bill under Q0175 LEAST EXPENSIVE FIRST
33 NDCs map to Q0175. Bill units = how many HCPCS units one package represents.
| NDC (11-digit) | Drug | Labeler | Package | Strength | Bill units | NADAC / unit | Status | Source |
|---|---|---|---|---|---|---|---|---|
| 33342-0450-11 | Perphenazine 8 mg/1 TABLET | Macleods | 100 TABLET in 1 BOTTLE (33342-450-11) | 8 mg/1 | 2 | $0.135 | ● Active | PDAC |
| 23155-0801-01 | PERPHENAZINE 8 mg/1 TABLET | Heritage | 100 TABLET in 1 BOTTLE (23155-801-01) | 8 mg/1 | 2 | $0.135 | ● Active | PDAC |
| 68382-0593-01 | perphenazine 8 mg/1 TABLET | Zydus | 100 TABLET in 1 BOTTLE (68382-593-01) | 8 mg/1 | 2 | $0.135 | ● Active | PDAC |
| 00781-8048-01 | Perphenazine 8 mg/1 TABLET, FILM COATED | Sandoz | 100 TABLET, FILM COATED in 1 BOTTLE (0781-... | 8 mg/1 | 2 | $0.135 | ● Active | PDAC |
| 64980-0292-01 | PERPHENAZINE 8 mg/1 TABLET, FILM COATED | Rising | 100 TABLET, FILM COATED in 1 BOTTLE (64980... | 8 mg/1 | 2 | $0.135 | ● Active | PDAC |
| 52536-0168-01 | Perphenazine 8 mg/1 TABLET, FILM COATED | Wilshire | 100 TABLET, FILM COATED in 1 BOTTLE (52536... | 8 mg/1 | 2 | $0.135 | ● Active | PDAC |
| 33342-0449-11 | Perphenazine 4 mg/1 TABLET | Macleods | 100 TABLET in 1 BOTTLE (33342-449-11) | 4 mg/1 | 1 | $0.161 | ● Active | PDAC |
| 62135-0799-90 | Perphenazine 4 mg/1 TABLET | Chartwell | 90 TABLET in 1 BOTTLE (62135-799-90) | 4 mg/1 | 1 | $0.161 | ● Active | PDAC |
| 23155-0800-01 | PERPHENAZINE 4 mg/1 TABLET | Heritage | 100 TABLET in 1 BOTTLE (23155-800-01) | 4 mg/1 | 1 | $0.161 | ● Active | PDAC |
| 68382-0592-01 | perphenazine 4 mg/1 TABLET | Zydus | 100 TABLET in 1 BOTTLE (68382-592-01) | 4 mg/1 | 1 | $0.161 | ● Active | PDAC |
| 00781-8047-01 | Perphenazine 4 mg/1 TABLET, FILM COATED | Sandoz | 100 TABLET, FILM COATED in 1 BOTTLE (0781-... | 4 mg/1 | 1 | $0.161 | ● Active | PDAC |
| 64980-0291-01 | PERPHENAZINE 4 mg/1 TABLET, FILM COATED | Rising | 100 TABLET, FILM COATED in 1 BOTTLE (64980... | 4 mg/1 | 1 | $0.161 | ● Active | PDAC |
| 52536-0164-01 | Perphenazine 4 mg/1 TABLET, FILM COATED | Wilshire | 100 TABLET, FILM COATED in 1 BOTTLE (52536... | 4 mg/1 | 1 | $0.161 | ● Active | PDAC |
| 33342-0448-11 | Perphenazine 2 mg/1 TABLET | Macleods | 100 TABLET in 1 BOTTLE (33342-448-11) | 2 mg/1 | 0.5 | $0.197 | ● Active | PDAC |
| 23155-0799-01 | PERPHENAZINE 2 mg/1 TABLET | Heritage | 100 TABLET in 1 BOTTLE (23155-799-01) | 2 mg/1 | 0.5 | $0.197 | ● Active | PDAC |
| 68382-0591-01 | perphenazine 2 mg/1 TABLET | Zydus | 100 TABLET in 1 BOTTLE (68382-591-01) | 2 mg/1 | 0.5 | $0.197 | ● Active | PDAC |
| 00781-8046-01 | Perphenazine 2 mg/1 TABLET, FILM COATED | Sandoz | 100 TABLET, FILM COATED in 1 BOTTLE (0781-... | 2 mg/1 | 0.5 | $0.197 | ● Active | PDAC |
| 64980-0290-01 | PERPHENAZINE 2 mg/1 TABLET, FILM COATED | Rising | 100 TABLET, FILM COATED in 1 BOTTLE (64980... | 2 mg/1 | 0.5 | $0.197 | ● Active | PDAC |
| 52536-0162-01 | Perphenazine 2 mg/1 TABLET, FILM COATED | Wilshire | 100 TABLET, FILM COATED in 1 BOTTLE (52536... | 2 mg/1 | 0.5 | $0.197 | ● Active | PDAC |
| 33342-0451-11 | Perphenazine 16 mg/1 TABLET | Macleods | 100 TABLET in 1 BOTTLE (33342-451-11) | 16 mg/1 | 4 | $0.391 | ● Active | PDAC |
| 23155-0802-01 | PERPHENAZINE 16 mg/1 TABLET | Heritage | 100 TABLET in 1 BOTTLE (23155-802-01) | 16 mg/1 | 4 | $0.391 | ● Active | PDAC |
| 68382-0594-01 | perphenazine 16 mg/1 TABLET | Zydus | 100 TABLET in 1 BOTTLE (68382-594-01) | 16 mg/1 | 4 | $0.391 | ● Active | PDAC |
| 00781-8049-01 | Perphenazine 16 mg/1 TABLET, FILM COATED | Sandoz | 100 TABLET, FILM COATED in 1 BOTTLE (0781-... | 16 mg/1 | 4 | $0.391 | ● Active | PDAC |
| 64980-0293-01 | PERPHENAZINE 16 mg/1 TABLET, FILM COATED | Rising | 100 TABLET, FILM COATED in 1 BOTTLE (64980... | 16 mg/1 | 4 | $0.391 | ● Active | PDAC |
| 52536-0170-01 | Perphenazine 16 mg/1 TABLET, FILM COATED | Wilshire | 100 TABLET, FILM COATED in 1 BOTTLE (52536... | 16 mg/1 | 4 | $0.391 | ● Active | PDAC |
| 00781-1046-10 | PERPHENAZINE 2 MG | Unknown | — | — | 0.5 | — | — | PDAC |
| 00781-1048-01 | PERPHENAZINE 8 MG | Unknown | — | — | 2 | — | — | PDAC |
| 00781-1048-13 | PERPHENAZINE 8 MG | Unknown | — | — | 2 | — | — | PDAC |
| 00781-1049-01 | PERPHENAZINE 16 MG | Unknown | — | — | 4 | — | — | PDAC |
| 00781-1047-13 | PERPHENAZINE 4 MG | Unknown | — | — | 1 | — | — | PDAC |
| 00781-1047-01 | PERPHENAZINE 4 MG | Unknown | — | — | 1 | — | — | PDAC |
| 00781-1046-13 | PERPHENAZINE 2 MG | Unknown | — | — | 0.5 | — | — | PDAC |
| 00781-1046-01 | PERPHENAZINE 2 MG | Unknown | — | — | 0.5 | — | — | PDAC |
NDC→HCPCS mappings come from the CMS ASP NDC-HCPCS crosswalk; additional DME MAC / DMEPOS mappings come from PDAC and are labeled separately. NADAC from CMS (weekly). “Status” reflects the product's marketing / obsolete flag in the NDC directory. Presence or absence here does not determine Medicare coverage. Linked NDCs open the full product page.
🗺️ Where Q0175 is utilized
⏳
The geographic utilization map is building for this code — it aggregates millions of CMS Part B claim lines, then caches the result. Refresh in a moment; if it doesn’t appear, this code may have no reportable Part B utilization.
📊 What bills under Q0175
J-codes are billing codes often used for drugs billed under the medical benefit. This connects the billing code to the NDC package records it covers, by ingredient and labeler.
NDC products by ingredient
NDC products by labeler
🗃️ Data sources & freshness
Every figure on this page is computed from public datasets. Here's what each section draws on and how current it is.
HCPCS code & descriptor
CMS HCPCS Level II code file
Loaded
Payment limit & billing unit
CMS Medicare Part B ASP Pricing File (quarterly)
Not available
NDC ↔ HCPCS crosswalk
CMS ASP NDC-HCPCS crosswalk + DMEPDAC (PDAC)
33 NDCs mapped
NADAC acquisition cost
CMS National Average Drug Acquisition Cost (weekly)
Available for mapped NDCs
Utilization & spend
CMS Part B Spending by Drug · PSPS · Physician & Other Practitioners
No reportable utilization
Figures are estimates for reference and may lag the source files. Always verify against the current CMS files and your payer's policy before submitting claims.
⚠️ Practical billing caveats
- A crosswalk is not coverage. An NDC mapping or a published payment limit does not guarantee a payer will cover or pay this code. Check the specific plan's policy.
- Units ≠ milligrams. Bill the number of HCPCS units (dose ÷ the code's unit size), not the milligram dose. Use the calculator above.
- Discarded drug. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (and JZ when nothing is discarded) where the payer allows.
- Rounding & partial units. Many payers require whole units; round per the payer's policy, not automatically up.
- The code can cover more than this drug. Some HCPCS codes span multiple products or strengths — confirm the exact code for the product administered.
- Figures lag. ASP limits change quarterly and utilization data are released with a delay. Verify against the current CMS files before billing.
❓ Q0175 billing FAQ
What is HCPCS code Q0175?
Q0175 is a HCPCS Level II Q-code used to bill Perphenazine, 4 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen under Medicare Part B and most medical (not pharmacy) benefits.
Which NDCs bill under Q0175?
33 NDCs currently map to Q0175 in the CMS ASP NDC-HCPCS crosswalk. See the NDC crosswalk table above for each product, package, billing units and estimated reimbursement.
Does a crosswalk mean Q0175 is covered?
No. An NDC-to-HCPCS crosswalk and a published payment limit do not guarantee coverage or payment. Coverage depends on the payer, the diagnosis and the site of care — always verify the current policy before billing.
For professional billing reference only — verify against the current CMS files before submitting claims.